Dermapharm Holding SE (FRA:DMP)

Dermapharm Holding SE Statistics

Total Valuation

FRA:DMP has a market cap or net worth of EUR 1.76 billion. The enterprise value is 2.61 billion.

Market Cap	1.76B
Enterprise Value	2.61B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	Jun 27, 2025

Share Statistics

Current Share Class	53.84M
Shares Outstanding	n/a
Shares Change (YoY)	-0.35%
Shares Change (QoQ)	-0.57%
Owned by Insiders (%)	6.79%
Owned by Institutions (%)	13.93%
Float	8.85M

Valuation Ratios

The trailing PE ratio is 16.45 and the forward PE ratio is 13.56.

PE Ratio	16.45
Forward PE	13.56
PS Ratio	1.48
PB Ratio	2.91
P/TBV Ratio	n/a
P/FCF Ratio	10.06
P/OCF Ratio	8.18
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.87, with an EV/FCF ratio of 14.87.

EV / Earnings	24.32
EV / Sales	2.19
EV / EBITDA	9.87
EV / EBIT	11.28
EV / FCF	14.87

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 1.67.

Current Ratio	1.84
Quick Ratio	0.78
Debt / Equity	1.67
Debt / EBITDA	3.84
Debt / FCF	5.76
Interest Coverage	4.30

Financial Efficiency

Return on equity (ROE) is 18.23% and return on invested capital (ROIC) is 8.84%.

Return on Equity (ROE)	18.23%
Return on Assets (ROA)	6.62%
Return on Invested Capital (ROIC)	8.84%
Return on Capital Employed (ROCE)	12.95%
Revenue Per Employee	335,393
Profits Per Employee	30,188
Employee Count	3,610
Asset Turnover	0.55
Inventory Turnover	1.24

Taxes

In the past 12 months, FRA:DMP has paid 57.64 million in taxes.

Income Tax	57.64M
Effective Tax Rate	35.24%

Stock Price Statistics

The stock price has increased by +3.95% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+3.95%
50-Day Moving Average	32.81
200-Day Moving Average	35.89
Relative Strength Index (RSI)	52.95
Average Volume (20 Days)	36

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:DMP had revenue of EUR 1.19 billion and earned 107.20 million in profits. Earnings per share was 1.99.

Revenue	1.19B
Gross Profit	755.65M
Operating Income	229.91M
Pretax Income	163.55M
Net Income	107.20M
EBITDA	256.68M
EBIT	229.91M
Earnings Per Share (EPS)	1.99

Balance Sheet

The company has 162.69 million in cash and 1.01 billion in debt, giving a net cash position of -846.87 million.

Cash & Cash Equivalents	162.69M
Total Debt	1.01B
Net Cash	-846.87M
Net Cash Per Share	n/a
Equity (Book Value)	605.49M
Book Value Per Share	11.35
Working Capital	302.29M

Cash Flow

In the last 12 months, operating cash flow was 215.52 million and capital expenditures -40.17 million, giving a free cash flow of 175.35 million.

Operating Cash Flow	215.52M
Capital Expenditures	-40.17M
Free Cash Flow	175.35M
FCF Per Share	n/a

Margins

Gross margin is 63.45%, with operating and profit margins of 19.30% and 9.00%.

Gross Margin	63.45%
Operating Margin	19.30%
Pretax Margin	13.73%
Profit Margin	9.00%
EBITDA Margin	21.55%
EBIT Margin	19.30%
FCF Margin	14.72%

Dividends & Yields

This stock pays an annual dividend of 0.90, which amounts to a dividend yield of 2.74%.

Dividend Per Share	0.90
Dividend Yield	2.74%
Dividend Growth (YoY)	2.27%
Years of Dividend Growth	n/a
Payout Ratio	44.20%
Buyback Yield	0.35%
Shareholder Yield	3.09%
Earnings Yield	6.08%
FCF Yield	9.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:DMP has an Altman Z-Score of 2.14 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.14
Piotroski F-Score	8